Envestnet Asset Management Inc. reduced its position in shares of Stepan (NYSE:SCL – Free Report) by 31.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,213 shares of the basic materials company’s stock after selling 1,970 shares during the period. Envestnet Asset Management Inc.’s holdings in Stepan were worth $273,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Versant Capital Management Inc lifted its stake in shares of Stepan by 110.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the basic materials company’s stock valued at $30,000 after buying an additional 240 shares in the last quarter. KBC Group NV lifted its position in Stepan by 40.8% in the 4th quarter. KBC Group NV now owns 1,315 shares of the basic materials company’s stock valued at $85,000 after acquiring an additional 381 shares in the last quarter. Entropy Technologies LP acquired a new position in Stepan during the 4th quarter valued at about $239,000. Howe & Rusling Inc. increased its holdings in Stepan by 24.5% during the 4th quarter. Howe & Rusling Inc. now owns 4,254 shares of the basic materials company’s stock worth $275,000 after purchasing an additional 837 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Stepan in the fourth quarter worth approximately $324,000. Institutional investors own 82.70% of the company’s stock.
Stepan Stock Up 0.1 %
Shares of NYSE:SCL opened at $53.64 on Wednesday. Stepan has a 1 year low of $44.23 and a 1 year high of $94.77. The company has a market capitalization of $1.21 billion, a PE ratio of 24.27 and a beta of 1.00. The business has a fifty day moving average price of $53.21 and a two-hundred day moving average price of $63.35. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.21 and a quick ratio of 0.86.
Stepan Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be issued a dividend of $0.385 per share. This represents a $1.54 annualized dividend and a yield of 2.87%. The ex-dividend date of this dividend is Friday, May 30th. Stepan’s dividend payout ratio (DPR) is presently 62.60%.
Insider Buying and Selling at Stepan
In other Stepan news, Director Susan Lewis bought 500 shares of the stock in a transaction on Tuesday, February 25th. The shares were acquired at an average price of $63.53 per share, with a total value of $31,765.00. Following the acquisition, the director now directly owns 1,896 shares of the company’s stock, valued at $120,452.88. The trade was a 35.82 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 7.60% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com raised shares of Stepan from a “hold” rating to a “buy” rating in a report on Thursday, May 1st.
Get Our Latest Stock Report on Stepan
Stepan Company Profile
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.
Further Reading
- Five stocks we like better than Stepan
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Health Care Stocks Explained: Why You Might Want to Invest
- The Top-Ranked Insider Buys From April by Market Cap
- What is the Nasdaq? Complete Overview with History
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Want to see what other hedge funds are holding SCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stepan (NYSE:SCL – Free Report).
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.